about
Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.Automated image analysis of lung branching morphogenesis from microscopic images of fetal rat explants.RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapyDisruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 statusTargeting lactate transport suppresses in vivo breast tumour growthKnock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER InhibitorsGlucose Addiction in Cancer Therapy: Advances and Drawbacks.Gene disruption using zinc finger nuclease technology.Value of pH regulators in the diagnosis, prognosis and treatment of cancer.Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiologyGLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.The monocarboxylate transporter inhibitor α-cyano-4-hydroxycinnamic acid disrupts rat lung branching.Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells.The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation.Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy.Rational Identification of a Colorectal Cancer Targeting Peptide through Phage DisplayIL-17A and IL-17F orchestrate macrophages to promote lung cancerImmunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for ImmunotherapyFucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivoA novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems
P50
Q34146377-AFAE2630-1EA9-43F1-8C86-249CF9B6BA3EQ34177193-FE0B60FE-C362-4841-873D-DA57E0CE53B0Q34634649-6C617F06-BFEB-44E3-AAD5-54FC042C7EBFQ35740054-2C9FAA56-ACA8-4DC7-8696-ED1FCFBD8424Q36326353-AA9F9B8B-DA07-4128-9BE3-EB9DC35720CEQ36413000-32D1CF10-DCB2-4A1D-8633-F47C1A88B71DQ36688989-02613ED2-6EA2-453A-85EF-32BBA2DA704CQ37143080-5AC9C0C2-F382-4331-B751-53ADA7CADF5BQ37564738-0816E55C-5775-445F-B5BA-C343A5269C98Q37668572-B58AA0E7-2F58-4292-85A0-A2071E90B0BEQ38616963-917D75D2-EE3C-46FF-BB2A-A2802D40F98EQ38993931-B3FFD81A-3843-483D-A846-2EF8AAA4FD05Q39075289-B309B6F2-BAFD-4A47-B768-6992477738B2Q42284739-A10EFCB5-70A9-40C5-9620-9662EDDD18B6Q42362770-7427A8D6-3B88-4964-89AC-CD0EED82C1CBQ46546362-799A0D7E-4BFC-48A1-8623-28B1A18634F5Q47114557-4AB95EB8-C417-403F-B6E1-54E03287A428Q51599100-9C790E44-DCDC-4393-84AF-5C55AD0748ECQ55456951-A057BE77-930C-4EEA-B3EA-C6D3AB7EFCB2Q64118475-FAA10F40-39A3-4CBD-8346-5FDD03027BF0Q90751426-B7BB34B8-10AA-404A-BD83-91F1DD5F6B5EQ92632984-23FF8371-A593-4539-BD22-BAC3B95AFBFAQ92705934-79F0D4AD-DF3F-4F95-9A93-F392312C39C6Q92935120-A99DA265-C8D1-4CDB-90EC-F7B2154405B7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Granja
@ast
Sara Granja
@en
Sara Granja
@es
Sara Granja
@nl
Sara Granja
@sl
type
label
Sara Granja
@ast
Sara Granja
@en
Sara Granja
@es
Sara Granja
@nl
Sara Granja
@sl
prefLabel
Sara Granja
@ast
Sara Granja
@en
Sara Granja
@es
Sara Granja
@nl
Sara Granja
@sl
P106
P1153
54912758700
P21
P31
P496
0000-0001-8717-6751